Brookline Capital Management Equities Analysts Increase Earn

Brookline Capital Management Equities Analysts Increase Earnings Estimates for X4 Pharmaceuticals, Inc. (NASDAQ:XFOR)

X4 Pharmaceuticals, Inc. (NASDAQ:XFOR – Free Report) – Equities research analysts at Brookline Capital Management increased their FY2026 earnings estimates for X4 Pharmaceuticals in a research report issued to clients and investors on Monday, April 29th. Brookline Capital Management analyst L. Cann now expects that the company will earn $0.32 per share for the year, […]

Related Keywords

Adams Mostafa , , Barclays Plc , Sg Americas Securities , Securities Exchange Commission , Pharmaceuticals Stock , Pharmaceuticals Inc , Pharmaceuticals Daily , Nasdaq , Capital Partners , Stonepine Capital Management , Free Report , Brookline Capital Management , Capital Management , Get Free Report , Exchange Commission , X4 Pharmaceuticals , Nasdaq Xfor , Wexfor , Medical , Earnings Estimates ,

© 2025 Vimarsana